accessibility menu, dialog, popup

UserName

New Feature

You can now browse the site in English or Deutsch.

Outcome Certainty Life Sciences

New Invitrogen SuperScript V Reverse Transcriptase

September 2026 | 1 min read | By: Invitrogen
New Invitrogen SuperScript V Reverse Transcriptase

Building on the proven performance of Invitrogen™ SuperScript™ IV Reverse Transcriptase, Invitrogen™ SuperScript™ V has been engineered to deliver high-quality cDNA with exceptional sensitivity and robustness, including when working with challenging sample types such as FFPE tissue, low-input samples, and partially degraded RNA.

SuperScript V provides an important new opportunity to engage customers looking for greater performance, speed, and flexibility in their reverse transcription workflows.

What makes SuperScript V different?

SuperScript V introduces several meaningful workflow innovations designed to make reverse transcription faster, easier, and more flexible.

Key Benefits Include:

  • Exceptional sensitivity and robustness across diverse and challenging sample types
  • Rapid reaction times to help customers accelerate their workflows
  • Room-temperature shipping, storage, and setup, providing greater flexibility and control at the bench
  • Reduced cold-chain requirements, designed to help reduce environmental impact
  • Animal origin-free and DTT-free formulation

Together, these improvements provide a compelling reason to start conversations with both existing SuperScript users and customers looking to optimize their current reverse transcription workflows.